UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
NKGN holding history
NKGen Biotech, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKGN overviewAll 13F holders of NKGNFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −763−100.0% | Sold out | Holders |
| Q4 2024 | 763 | $500 | <0.1% | −13,883−94.8% | Reduced | Holders |
| Q3 2024 | 14,646 | $5.54K | <0.1% | −29,171−66.6% | Reduced | Holders |
| Q2 2024 | 43,817 | $55.6K | <0.1% | +32,728+295.1% | Added | Holders |
| Q1 2024 | 11,089 | $21.0K | <0.1% | +11,089 | New | Holders |